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during acidic conditions, and increased the expression levelsPTH ameliorates acidosis-induced adverse effects in skeletal
of IGF-1 and IGF-1 receptor in the acidotic condyle. Acidosisgrowth centers: The PTH–IGF-I axis.
increased the expression of IGF-I binding protein-4 (IGFBP-4,Background. Chronic metabolic acidosis (CMA) exerts pro-
an inhibitor of IGF-I activity), whereas coincubation with PTHfound adverse effects on bone metabolism thereby leading to
during acidic conditions abrogated the up-regulation of IGFBP-4.impaired skeletal linear growth. We have recently shown that
CMA in vitro causes distinct morphological changes in skeletal Addition of a neutralizing antibody to IGF-I-R during PTH
growth centers along with inhibition of endochondral differen- treatment under acidic conditions resulted in the abrogation
tiation. In addition, CMA causes an end organ resistance to the of the ameliorative effect of PTH on endochondral differentia-
anabolic effects of growth hormone (GH) and locally produced tion. The protein kinase C (PKC) signaling pathway was modu-
insulin-like growth factor-I (IGF-I) in skeletal growth centers. lated negatively by CMA. However, PTH activated PKC-alpha
Given the effects of parathyroid hormone (PTH) and PTH under both control and acidic conditions. The phorbol ester,
related protein (PTHrP) on the development of cartilaginous PMA (phorbol 12-myristate 13-acetate), a PKC activator, mim-
bone, we sought to determine whether PTH has any effects icked the effect of PTH on chondrocyte differentiation.
on the changes induced by CMA in skeletal growth centers. Conclusion. Parathyroid hormone at low concentration stim-
The interaction between PTH and IGF-I in growth centers ulates the differentiation and proliferation of cartilage cells and
during neutral or acidic conditions were studied specifically. prevents the suppressive effect of acidosis on endochondral
Methods. An in vitro organ culture system using the murine bone differentiation and on the IGF-I/IGF-I-R system in skele-
mandibular condyle was employed as a model for endochondral tal growth centers. Increased local production of IGF-I by PTH,
active growth center. Condyles from six-day-old mice were which takes place even during acidotic conditions, mediates, at
cultured in BGJb medium of either neutral pH (pH 7.4) or least in part, the ameliorative effect of PTH. Protein kinase C is
acidic pH (pH7.15) in the presence or absence of 1010 mol/L probably one of the signaling pathways mediating the salutary
[1–34] PTH. After 24, 48, 72 and 96 hours of culture, the effects of PTH on chondrocyte differentiation in growth cen-
condyles were washed, fixed in formaldehyde, and processed ters. This study lends further credence to the notion that under
for paraffin embedding. Histologic markers of the growth cen- certain conditions, PTH or PTHrP can exert anabolic effects
ter were assessed. In addition, the protein level and mRNA in the skeleton. These findings may be of clinical-therapeutic
expression for various markers of cartilage differentiation were significance in children and patients with CMA.
evaluated by immunohistochemistry and in situ hybridization,
respectively. The abundance and expression levels of IGF-I
and IGF-I receptor (IGF-I-R) were assessed also.
Results. Following incubation for 72 hours in acidic condi- During endochondral bone formation, the growth
tions, there was a marked attenuation of the chondroblastic zone, plate chondrocytes proliferate, differentiate into chondro-
suggesting a defect in the process of cellular differentiation.
blasts synthesizing type II collagen, become hypertrophicAcidosis also down-regulated endochondral differentiation
changing their program of matrix synthesis (for example,markers (cartilage specific proteoglycans, collagen type II).
This was accompanied by a reduction in the expression of IGF-1, from type II collagen to type X collagen), lose the carti-
IGF-1 receptor and PTH receptors. PTH (1010 mol/L) added lage phenotype, undergo mineralization, and provide a
to acidic cultures prevented the adverse effects of CMA on scaffold upon which subsequent longitudinal bone growthendochondral differentiation and increased the overall condylar
occurs.growth, when compared to acidic conditions without PTH.
Chronic metabolic acidosis (CMA) exerts profoundPTH also up-regulated its own receptor in control as well as
adverse effects on bone metabolism [1]. This may be
reflected clinically by growth retardation in children suf-Key words: chronic metabolic acidosis, IGF-I, PTH, skeletal growth
center, mandibular condyle, protein kinase C. fering from chronic acidosis (for example, uremic acido-
sis and renal tubular acidosis) [2–4] and by reduced bone
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effects of in vitro CMA on the morphology and integrity effects of PTH/PTHrP in bone are partly mediated by
of the cartilage zone in skeletal growth centers [9]. More increased local production of growth factor such as IGF-I
specifically, we have put a lot of emphasis on the growth and transforming growth factor- (TGF-) [25–28].
hormone (GH)–insulin-like growth factor-I (IGF-I) endo- With the foregoing background in mind, we wanted
crine axis, given the fundamental role played by these to address two questions:
hormones (acting in a paracrine/autocrine fashion) in
maintaining proliferation and differentiation of chondro- 1. Given the anabolic effects of PTH/PTHrP in the
cytes in growth centers [10–12]. Our study has shown that skeleton, can PTH modulate the negative effects
CMA exerts distinct morphological changes in growth exerted by CMA in skeletal growth centers?
centers and also suppresses differentiation of chondro- 2. Given the complexity of the PTH/PTHrP–GH–
cytes [9]. CMA also creates a state of end-organ resis- IGF-I interrelationship, does PTH exert any effects
tance to GH and IGF-1. This finding is attributable to on CMA induced changes in bone via the GH/IGF-I
reduced expression of the receptors for both hormones pathway?
and to increased expression of IGF binding proteins
(IGFBPs) 2 and 4, both of which are considered negative For the purpose of conducting the relevant experi-
modulators of IGF-I bioactivity [9]. ments, we used the organ culture preparation of the
The present study focuses on the interrelationship be- mouse mandibular condyle. This model, used extensively
tween parathyroid hormone (PTH) and the IGF-I endo- in our laboratory, manifests the various cellular layers
crine system during CMA. Parathyroid hormone (PTH), characteristic of an endochondral bone formation site,
a systemic regulator of skeletal metabolism, and parathy- and therefore is suitable for our current study [9, 29].
roid hormone-related protein (PTHrP), an autocrine/
paracrine regulator of tissue development, exert direct
METHODSeffects on skeletal cells that express a membrane receptor
that both ligands can bind [13–15]. Although tradition- Culture system
ally regarded as bone resorbing (that is, “catabolic”)
Mandibular condyles derived from six-day-old ICR
hormones, PTH/PTHrP, under certain conditions, can
(Institute of Cancer Research, New York, NY, USA)exert anabolic effects on bone metabolism. Thus, inter-
mice were aseptically dissected, and cultured as pre-mittent application of PTH stimulates bone formation
viously described [9, 29]. Cultures were fed with BGJbin laboratory animals [16, 17] as well as in human beings
medium (Fitton Jakchson Modification, Beth Haemek,[18–20]. In a most recent clinical study, daily subcutane-
Israel) supplemented with 2% fetal calf serum (FCS),ous injection of PTH [1–34] to postmenopausal osteopo-
100 g/mL ascorbic acid, and antibiotics. The tissuesrotic women resulted in increased bone mineral density
were incubated at 37C, 5% CO2/95% air, and maximaland decreased risk of vertebral and nonvertebral frac-
humidity in the presence or absence of 1010 mol/L rattures [20].
[1–34] PTH (cat. No. P1803; Sigma Chemical Co., St.As part of their effect on the skeleton, PTH and
Louis, MO, USA) or 108 mol/L phorbol 12-myristate-PTHrP also act in the cartilaginous portion of skeletal
13-acetate (PMA; cat. No. p8139; Sigma) under acidicgrowth centers and, thus, both PTHrP (acting in an auto-
or normal conditions. Acidosis (pH 7.1 to 7.15) wascrine/paracrine fashion) and PTH (acting mainly system-
achieved by addition of 2.4 mmol/L HCl to the medium.ically) exert distinct effects on both the proliferation
Culture medium was changed every day. The pH of theand the differentiation of chondrocytes via a negative
medium was checked every two days by a pH electrode.feedback loop involving the soluble factor Indian Hedge-
The pH values remained constant throughout the incuba-hog (Ihh) and its targets Patched (Ptc) and Gli [21, 22].
tion period. In preliminary experiments, condyles wereSeveral studies using knockout mice have demonstrated
incubated in either neutral or acidic conditions for 24,that in the absence of PTHrP or its receptor, chondro-
48, 72 and 96 hours. In most studies, marked changes ofcytes do not proliferate normally, giving rise to shortened
acidosis on morphology and on differentiation and thebones. Differentiation into hypertrophic cells is acceler-
IGF-I system were initially seen after 72 hours (3 days).ated, so that the extracellular matrix is mineralized pre-
Therefore, unless specified otherwise, cultures undermaturely and cells undergo early apoptosis [15, 23]. A
control or acidic conditions were studied following incu-reciprocal alteration in bone formation is observed in
bation for 72 hours.a constitutively-active PTH/PTHrP receptor mutant in
For IGF-I–receptors’ immuno-inhibition, condyles wereJansen-type metaphyseal chondrodysplasia [24].
incubated in the presence of anti-IGF-I–receptors anti-Aside from affecting the proliferation/differentiation
bodies (discussed later in this article), diluted 1/500 incycle of chondrocytes, PTH also is involved in the main-
the culture medium. At the end of the incubation period,tenance of cartilage phenotype reflected as increased syn-
thesis of cartilage specific proteoglycans [25]. The anabolic the explants were thoroughly washed with cold Hanks’
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buffer, fixed with neutral buffered formalin, and rou- In situ hybridization
tinely processed for paraffin embedding. Paraffin sections (6 m) were loaded on precleaned
poly-l-lysine-coated slides, deparaffinized with xylene,
Alcian blue and hematoxylin/eosin staining hydrated with graduated ethanols, and treated with 3%
Paraffin sections (6m) were deparaffinized in xylene, H2O2 in methanol to neutralize endogenous peroxidase.
hydrated in graduated ethanols, and pretreated with 3% Sections were then treated for 15 minutes with 12.5g/mL
acetic acid for three minutes. Sections then were stained proteinase K, rinsed with 2 mg/mL glycine, and ace-
with 1% Alcian blue (AB) at pH 2.5 for 30 minutes, tylated in 0.5% acetic anhydride in 0.1 mol/L Tris at
thoroughly rinsed with tap water, and counterstained pH 8.0. Thereafter, sections were post-fixed with 4%
with hematoxylin and eosin (H&E). paraformaldehyde/phosphate buffered saline (PBS). Pre-
hybridization for 10 seconds in 2 standard saline citrate
Morphometric studies (SSC) was followed by one hour in hybridization buffer:
Alcian blue and H&E-stained sections were used in 50% formamide 0.5 mg/mL salmon sperm DNA, 4 
the morphometric studies. The length of the mandibular SSC, 1  Denhardt solution, 200 U/mL heparin, 5%
condyle was determined with an Olympus Cue-2 image dextran sulfate and 0.01% sodium dodecyl sulfate (SDS).
analysis system with appropriate morphometry software Hybridization was done overnight (18 hours) at 42C and
(Olympus Corporation, Lake Success, NY, USA). The maximal humidity with a 5 g/mL digoxygenin labeled
system consists of a Zeiss Universal R photomicroscope anti-sense RNA probe (discussed later in this article).
(10 objective) fitted with a Panasonic WV-CD50 cam- At the end of the incubation period, slides were rinsed
era. The video image is viewed on a Sony 14 inch color in SSC under increasing stringency conditions and then
monitor attached to an IBM-compatible PC. with 0.1 mol/L Tris-0.15 mol/L NaCl at pH 7.5. Hybrids
were detected using anti-digoxygenin antibodies conju-
Immunohistochemistry gated with peroxidase (Boehringer Mannheim, Mann-
Deparaffinized paraffin sections were reacted for two heim, Germany) and aminoethyl carbonate (AEC) as a
hours at room temperature with one of the following substrate; counterstaining was done with hematoxylin.
specific antibodies: rabbit anti-PTH receptor (cat. No.
Digoxygenin-labeled antisense RNA probes forPRB-620P BAbCO, Santa Cruz Biotechnology, Santa
in situ hybridizationCruz, CA, USA), rabbit anti-IGF-I receptor (anti- sub-
unit, cat. No. SC-712; Santa Cruz Biotechnology), mouse Probes were used for mouse IGF-IR (417 bp) cloned
anti-collagen type II (cat. No. MAB 8887; Chemicon in pBluescript SK amp, for the core protein of the
International Inc., Temecula, CA, USA) or mouse anti- cartilage specific proteoglycan (CSPG) cloned in pBlue-
IGF-I (cat No. 05-172; Upstate Biotechnology, Lake script SK amp (922 bp) or for IGFBP-4 (444 bp), also
Placid, NY, USA). This was followed by incubation with cloned in pBluescript SK amp. After linearization,
an appropriate biotinylated second antibody, with strep- digoxygenin-labeled antisense RNA was transcribed us-
tavidin-peroxidase conjugate, and S-(2-aminoethyl)-l- ing the (Sp6/T7) Dig-RNA labeling kit (Boehringer
cysteine (AEC) as a substrate (Histostain-SP kit; Zymed Mannheim), according to the manufacturer’s instruc-
Lab Inc., San Francisco, CA, USA). Counterstaining was tions. The specificity of the various probes was verified by
done with hematoxylin. introducing in each hybridization assay control sections
hybridized with the relevant digoxygenin-labeled sense
SDS-PAGE and Western blotting mRNA. In all cases, these controls were negative. In the
Tissue lysates prepared from pools of three-day-old case of the CSPG probe, we also examined its ability to
cultured mandibular condyles treated with 1010 mol/L react with skin proteoglycans and the intensity of the
PTH, under acidic conditions or under control conditions staining was negligible.
were separated by reducing sodium dodecyl sulfate-poly-
Statisticsacrylamide gel electrophoresis (SDS-PAGE) and elec-
tro-transferred to nitrocellulose membrane. Blots were Each point in the morphometric studies represents a
incubated with rabbit anti-IGF-I receptors, mouse anti- mean of measurements performed in three to five differ-
protein kinase C (anti-PKC) alpha (cat. No. SC 8393; ent experiments, with at least three condyles cultured
Santa Cruz Biotechnology) or mouse anti- actin (cat. under each culture conditions in each experiment and
No. MAB 1501; Chemicon International Inc.) and de- at least three measurements of each condyle. Means of
tected by rabbit anti-mouse-horseradish peroxidase (HRP) 20 to 70 measurements were calculated in the various
(Sigma) or goat anti rabbit-HRP conjugates (Upstate morphometric analyses.
Biotechnology), and revealed by chemiluminescence re- Significance was analyzed with the Student two-tailed
t test.agent (New England Nuclear, Boston, MA, USA).
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RESULTS size of the condyle by 27% as compared to acidosis alone,
without PTH (P  0.001). Thus, PTH abolished theChronic metabolic acidosis
inhibitory effect of acidosis on the overall size of the
Chronic metabolic acidosis (CMA) caused down-regu-
mandibular condyle. PTH under control (neutral pH) con-
lation of PTH receptors, while PTH up-regulated its own
ditions increased the condylar width by 6% (P  0.05).
receptor under control and acidic conditions.
Mandibular condyles derived from six-day-old ICR mice PTH prevented the acidosis-induced inhibition of
were cultured for three days under control (Fig. 1 A, C) Type II collagen
or acidic (Fig. 1 B, D) conditions, and in the presence To further characterize the effects of PTH on the dif-
(Fig. 1 C, D) or absence (Fig. 1 A, B) of PTH. The ferentiation of growth centers, the effect of PTH on the
condyles were fixed and routinely processed for paraffin expression level of type II collagen, a major component
embedding as described above. PTH receptors were lo- of the certilaginous matrix, was examined. Figure 4B
calized immunohistochemically using anti-PTH receptor shows that acidosis (72 hours) decreased the expression
antibodies. As shown in Figure 1B, acidosis decreases of collagen type II at the protein level when compared
the expression level of PTH receptors when compared to control conditions (Fig. 4A). PTH 1010 mol/L alone
to control conditions (Fig. 1A). Coincubation of the con- increased the expression of type II collagen (Fig. 4C),
dyle with rat PTH [1–34] (1010 mol/L) for 72 hours and it also prevented the acidosis-induced inhibition of
brings about an up-regulation of PTH receptors both type II collagen (Fig. 4 D vs. B). Immunoreactivity was
under control (Fig. 1C) or acidic conditions (Fig. 1D). detected in the extracellular matrix from chondroblastic
Incubation of the condyle with a high concentration of to the hypertrophic zone, through the entire differenti-
PTH (108 mol/L) for 72 hours brought about a down- ated area of the condyle.
regulation of PTH receptors both under control and
acidic conditions (data not shown). Based on the results PTH abolished the acidosis-induced inhibition of
described in Figure 1, in all subsequent studies involving cartilage-specific proteoglycans
incubation of organ cultures with PTH, the concentration The differentiation process of cartilage cells was ac-
of 1010 mol/L PTH was used, unless specified otherwise. companied by the production of specific proteoglycans.
Thus, the expression of the core protein of cartilage-Effects of PTH on acidosis-induced morphological
specific proteoglycans (CSPG) was considered as an earlyappearance of the mandibular condyle
index of chondrocytic differentiation. Therefore, we ex-
Hematoxylin and eosin stained sections of the mandib- amined the effects of PTH on the expression of CSPG
ular condyle under control conditions (Fig. 2A) demon- mRNA in the acidotic condyles by in situ hybridization
strated the normal developmental gradient of the condy- using a digoxygenin-labeled 922 bp riboprobe for the
lar cell population, namely, the chondroprogenitor zone core protein of CSPG. Figure 5 shows that 72 hours of
and flattened chondroblasts followed by, young, mature acidosis significantly reduced the expression of CSPG
and hypertrophic chondrocytes. This arrangement of cel- (Fig. 5B) as compared to control conditions (Fig. 5A).
lular gradient was obliterated under acidic conditions PTH 1010 mol/L alone increased the expression of CSPG
(Fig. 2B). Thus, chondroblasts and young chondrocytes mRNA (Fig. 5C) and it also abolished the acidosis-induced
were absent, leaving the hypertrophic cells to lie in an inhibition of CSPG expression (Fig. 5 D vs. B).
abnormal juxtaposition next to the progenitor cells. PTH
PTH abolished the inhibitory effect of acidosis on1010 mol/L prevented these effects of acidosis on the
IGF-I abundance in the cultured condylemorphological appearance of the condyle, and thereby
restored the normal cellular architecture during acidic We have recently shown that CMA inhibits IGF-I
conditions (Fig. 2 D vs. B). The figure also shows that in abundance in skeletal growth centers [9]. Since IGF-I
control (that is, neutral) conditions, PTH induced marked plays a cardinal role in maintaining the integrity of the
proliferation of chondroprogenitor cells (Fig. 2C). cartilage tissue in growth centers, and given our data
(Figs. 2–5) that PTH exerted a positive effect on the
PTH abolished the inhibitory effect of acidosis on the differentiation and growth of cartilage cells in the man-
overall size of the mandibular condyle dibular condyle, we studied the effects of PTH on IGF-I
The effect of PTH on the condylar growth was assessed under control and acidic conditions.
morphometrically. Hematoxylin/eosin-stained sections Figure 6 shows that acidosis (72 hours) decreased IGF-I
were used for morphometric analysis. Results in Figure abundance (Fig. 6B) compared to control conditions
3 reveal that acidic milieu decreased the condylar size (Fig. 6A). PTH 1010 mol/L increased the levels of IGF-I
by 22% (P  0.01 vs. control). Treatment with 1010 both under normal (Fig. 6 C vs. A) and acidic conditions
(Fig. 6 D vs. B).mol/L PTH under acidic conditions increased the overall
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Fig. 1. Effects of acidosis and parathyroid
hormone (PTH) on the level of PTH recep-
tors. Mandibular condyles derived from 6-day-
old ICR mice were incubated for 3 days under
control (A, C) or acidic conditions (B, D), in
the presence (C, D) or absence (A, B) of 1010
mol/L rat [1–34] PTH. At the end of the incu-
bation period, condyles were fixed with neu-
tral buffered formalin and routinely processed
for paraffin embedding as described in the
Methods section. Deparaffinized sections were
immunostained with anti PTH receptor anti-
bodies. The abundance of the PTH receptor
was assessed by immunohistochemistry as de-
scribed in the Methods section.
Fig. 2. Effects of acidosis and PTH on the
morphological appearance of the mandibular
condyle. Mandibular condyles derived from 6
day old ICR mice were incubated for 3 days
under control (A, C ) or acidic conditions
(B, D), in the presence (C, D) or absence
(A, B) of 1010 mol/L PTH, and processed for
paraffin embedding as described in Figure 1.
Deparaffinized sections were stained with
acidic (pH 2.5) Alcian blue  hematoxylin
and eosin (H&E). Abbreviations are: pr, pro-
liferative cells; ch, chondroblastic cells; hc, hy-
pertrophic cells.
PTH abolished the acidosis-induced decrease in on the expression of IGF-I-R at both the protein and
IGF-I-receptors mRNA levels were examined using immunohistochemis-
try and Western blot, and in situ hybridization, respec-Our previous study showed an acidosis-induced reduc-
tively. As already shown by us [9], Figure 7 again showstion in the responsiveness to IGF-I, which was partly
marked reduction of IGF-I-R at the protein level duringrelated to the reduced expressed of IGF-I receptors
(IGF-I-R) [9]. In our current study, the effects of PTH acidosis as compared to neutral conditions (Fig. 7 B vs. A).
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we examined the effects of PTH while blocking IGF-I
receptors. Cultures were incubated for 72 hours in con-
trol (Fig. 10A) or acidic conditions (Fig. 10B). PTH 1010
mol/L was added to the acidic incubation medium (10
C, D) in the absence (Fig. 10C) or the presence (Fig.
10D) of anti-IGF-I–receptor antibody (anti--subunit,
cat. No. SC-712; 1/500; Santa Cruz Biotechnology). The
effects of PTH on differentiation were assessed by ex-
pression of the core protein of CSPG. An in situ hybrid-
ization assay was used to assess the expression of CSPG
mRNA.
As already shown above, PTH abolishes the inhibitory
effect of acidosis on the expression of CSPG (Fig. 10
C vs. B). However, in cultures containing anti-IGF-I-R
antibodies, the beneficial effect of PTH is abrogated (Fig.
10 D vs. C). It appears, therefore, that the salutary effect
of PTH on differentiation of the condylar growth center
is mediated via production of IGF-I.
Fig. 3. Effects of acidosis and PTH on overall length of the condyle. PTH abrogated the acidosis-induced up-regulationStained paraffin sections (Alcian blueH&E) of control (neutral pH),
of IGFBP-4acidic cultures, PTH (1010 mol/L)-treated control cultures, and PTH-
treated acidic cultures (incubation for 3 days) were used for morphomet- Insulin-like growth factor-binding proteins (IGFBPs)ric analyses. The overall condylar length was measured from the apical
are important regulators of the biological activity of IGF-Iarticular surface of the condyle to the ossification front. Results show
a decrease of 22% (P  0.01 vs. control) in the overall size of the acidic as they can either enhance or reduce the effects of IGF-I
condyle, and an increase of 27% (P  0.001) in the thickness of the [10, 11]. IGFBP-4 is one of the negative modulators ofacidic condyle treated with 1010 mol/L PTH. The size of the PTH-
IGF-I activity. We have previously shown that part oftreated acidic condyle is not significantly different from that of the
control. (that is, neutral pH without PTH). This figure represents a the end-organ resistance to IGF-I in the mandibular con-
mean of measurements performed in 4 different experiments, with at dyle is attributable to increased expression of IGFBP-4least 4 condyles cultured under each culture condition, and at least 3
and IGFBP-2, because both of them antagonize IGF-Imeasurements carried out from each condyle.
activity under normal conditions [9]. Figure 11 again
shows that the expression of IGFBP-4 was up-regulated
PTH 1010 mol/L markedly increases the level of IGF-I during 72 hours of incubation in acidic conditions when
receptors in every cell layer of the chondrocytic popula- compared to neutral conditions (Fig. 11 B vs. A). PTH
tion, both under control (Fig. 7 C vs. A) and acidic 1010 mol/L negatively modulated the expression of
conditions (Fig. 7 D vs. B). IGFBP-4 (Fig. 11C) and abrogated the up-regulation of
Western blot analysis revealed that acidosis decreased
this protein under the acidic condition (Fig. 11 D vs. B).IGF-I-R by approximately 40% (Fig. 8). PTH markedly
Thus, CMA induced suppression of IGF-I activity onincreased the level of IGF-I-R during both control and
chondrocyte differentiation [9] as well as its recoveryacidic conditions.
by PTH were attributable not only to changes in theIn situ hybridization demonstrates that acidosis-induces
abundance and expression of IGF-I-R, but also to in-inhibition of IGF-I-R mRNA (Fig. 9B) when compared
creased and decreased IGFBP-4 by CMA and PTH, re-to control conditions (Fig. 9A). PTH 1010 mol/L up-
spectively.regulates the expression of IGF-I-R mRNA under control
conditions (Fig. 9 C vs. A) and abrogates the inhibitory Signal transduction pathways involved in the adverse
effect of acidosis on IGF-I-R mRNA (Fig. 9 D vs. B). effects of CMA and the salutary effects of PTH in
It appears, therefore, that the PTH-induced up-regula- growth centerstion of IGF-I receptors in the chondrocytic population
The binding of PTH and PTHrP to their commonof the mandibular condyle is exerted at the gene level.
receptor activates two major transduction pathways: (a)Parallel sections incubated with digoxygenin-labeled
stimulation of adenylyl cyclase to the cAMP dependentsense IGF-I-R riboprobe served as a negative control
activation of protein kinase A (PKA); and (b) phospho-(data not shown).
inositol breakdown by phospholipase C followed by the
Immuno-inhibition of IGF-I receptors blunts the activation of protein kinase-C (PKC) and an increase of
ameliorative effect of PTH in acidic conditions intracellular Ca2. Recently the PKC signaling pathway
has been shown to maintain chondrocyte differentiationTo evaluate the role played by IGF-I in mediating the
ameliorative effects of PTH on the acidotic condyle, and to mediate the biological effects of calciotropic hor-
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Fig. 4. Effects of PTH on the acidosis-induced
inhibition of type II collagen. Condyles were
cultured for 3 days under control (A, C) or
acidic conditions (B, D), in the presence (C, D)
or absence (A, B) of 1010 mol/L PTH, and
processed for paraffin embedding as described
in the Methods section. Deparaffinized sec-
tions were pretreated with 1 mg/mL pepsin in
10 mmol/L Tris-HCl, pH 2, for 10 minutes
at 37C, and reacted with mouse anti-type II
collagen antibody (cat. No. MAB 8887; Chem-
icon International, Inc.). The abundance of
type II collagen under the different conditions
was assessed by immunohistochemistry as de-
scribed in the Methods section.
Fig. 5. Effects of acidosis and PTH on the
expression of mRNA for cartilage-specific
proteoglycans (CSPG) core protein. Mandib-
ular condyles were cultured for 3 days under
control (A, C) or acidic conditions (B, D), in
the presence (C, D) or absence (A, B) of 1010
mol/L PTH, and processed for paraffin em-
bedding as described in the Methods section.
Following peroxidase blocking and permeabil-
ization (using 12.5 g/mL proteinase K), de-
paraffinized sections were reacted with 5g/mL
digoxygenin-labeled PGR (922 bp probe for
the core protein of the cartilage proteogly-
cans). Hybridization conditions and detection
of the hybrids were carried out as described
in the Methods.
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Fig. 6. Effects of acidosis and PTH on the
levels of IGF-I in the condyle. Paraffin sec-
tions derived from condyles cultured for 3
days under control (A, C) or acidic conditions
(B, D), in the presence (C, D) or absence (A, B)
of 1010 mol/L PTH, were immunoreacted
with mouse anti-IGF-I antibodies (cat No. 05-
172; Upstate Biotechnology). The abundance
of IGF-I protein was assessed by immunohisto-
chemistry as described in the Methods section.
Fig. 7. Effects of acidosis and PTH on the
levels of IGF-I receptor (IGF-I-R) in the con-
dyle. Mandibular condyles were incubated for
3 days under control (A, C) or acidic condi-
tions (B, D), in the presence (C, D) or absence
(A, B) of 1010 mol/L PTH and processed as
described in the Methods section. Immunohis-
tochemistry was performed by using rabbit
anti-IGF-I receptor antibodies (anti- subunit,
cat. No. SC-712, Santa Cruz Biotechnology).
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PTH at a concentration of 1010 mol/L promotes prolifer-
ation and differentiation of the mandibular condyle, and
also prevents the adverse effects of acidosis on the integ-
rity of the growth center at all stages of chondrocytic
differentiation. This salutary effect of PTH is mediated,
at least in part, by IGF-I, since inhibition of IGF-I recep-
tors by anti IGF-I-R antibody almost completely abol-
ished the ameliorative effect of PTH on the expression
of cartilage specific proteoglycans (Fig. 10). Although
this experiment only assessed the expression of CSPG
as a differentiation marker, we presume that other indi-
ces of differentiation (and probably proliferation) stimu-
lated by PTH, would be mediated by IGF-I also. How-
ever, it is possible that PTH exerts its beneficial effects
through other mediators in addition to IGF-I. Also, IGF-I
Fig. 8. Western analysis of IGF-I-R levels in acidic and PTH treated itself can act on downstream signals that in turn promote
condyles. Lysates derived from pools (10 to 15) of condyles cultured chondrocyte differentiation (for example, Cbfa 1).for 3 days under control and acidic conditions, with or without 1010
Our study also shows that CMA by itself (as comparedmol/L PTH, were separated on SDS-PAGE, electroblotted onto nitro-
cellulose membranes, and reacted with anti-IGF-IR antibodies. Equal to control conditions) causes down-regulation of PTH
amounts of protein were loaded onto each lane. The blot demonstrates receptors. It could be predicted, therefore, that CMAa marked decrease in the abundance of the receptor during acidotic
would lead to a state of resistance to PTH in skeletalconditions (compared to control). PTH up-regulates IGF-I-R in both
control and acidic conditions. growth centers. A similar finding of receptor down-regu-
lation is observed when control (nonacidotic) cells are
exposed to 72 hours of 108 mol/L PTH (that is, high
concentration). In contrast, when the cells are incubatedmones in skeletal growth centers [30, 31]. Based on these
for an identical time period with a lower PTH concentra-studies, we explored the possible involvement of PKC
tion (1010 mol/L), the receptors are not down-regulated,in mediating the respective effects of CMA and PTH in
either in the control or in the acidotic condition (Fig. 1).the mandibular condyle. Figure 12 shows a Western blot
This observation is consistent with the phenomenon ofanalysis using an antibody raised against the C-terminus
homologous down-regulation of PTH/PTHrP receptorof PKC-. Acidosis decreased PKC levels by approxi-
following prolonged exposure of the cells to PTH [32].mately 23% when compared to control. PTH 1010 mol/L
This phenomenon has been shown to be dose-relatedincreases the level of PKC during both control and acidic
and, thus, while 108 mol/L PTH is a dose that generallyconditions. Based on these results, we further evaluated
results in reduced mRNA and protein of the PTH recep-the effect of PKC on chondrocyte differentiation by incu-
tor, the concentration of 1010 mol/L PTH has much lessbating the organ culture with the phorbol ester PMA,
of an effect on the receptor level [32]. Interestingly, thean activator of PKC. By using cartilage specific proteo-
lower dose of PTH, incubated with the acidic condyleglycans (CSPG) expression as a marker of differentia-
for 72 hours, overcomes the inhibitory effect of acidosistion, Figure 13 demonstrates reduced expression of
per se on the expression of PTH receptors. Based onCSPG by CMA (Fig. 13 B vs. A), as already shown
these results, throughout our studies the concentrationearlier. PMA 108 mol/L stimulated CSPG expression
of 1010 mol/L PTH was used for coincubation of both(Fig. 13C) and also abolished the negative effect of CMA
control and acidotic organ cultures with the hormone.on CSPG (Fig. 13 D vs. B). It appears, therefore, that a
During endochondral bone formation, the growthleast part of the salutary effect of PTH on chondrocyte
plate chondrocytes proliferate, differentiate into chon-differentiation is attributable to the PKC transduction
droblasts synthesizing type II collagen, become hypertro-pathway.
phic changing their program of matrix synthesis (for ex-
ample, from type II collagen to type X collagen), lose
DISCUSSION the cartilage phenotype, undergo mineralization, and
provide a scaffold upon which subsequent longitudinalOur study demonstrates that CMA in vitro exerts a
profound negative effect on proliferation and differenti- bone growth occurs. Multiple autocrine, endocrine and
paracrine factors have been shown to influence endo-ation of chondrocytes in the mandibular condyle, a
model of skeletal growth center. The changes in differen- chondral bone formation [33]. These factors influence
the proliferation of chondrocytes or differentiation ortiation are reflected by altered expression of cartilage
specific proteoglycans, IGF-I, IGF-I-receptor, and type both. Among these factors, PTH (mainly of systemic
origin) and PTHrP (produced mainly locally in boneII collagen, a specific marker for cartilaginous matrix.
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Fig. 9. Effects of acidosis and PTH on the
expression of IGF-IR mRNA (in situ hybrid-
ization). Deparaffinized paraffin sections from
mandibular condyles cultured for 3 days under
control (A, C) or acidic conditions (B, D), in
the presence (C, D) or absence (A, B) of 1010
mol/L PTH and processed as described in the
Methods section, were hybridized with 5g/mL
digoxygenin-labeled antisense RNA probe for
IGF-I-R. Prehybridization and hybridization
processing were carried out as described in
Methods section.
Fig. 10. Effects of IGF-I-R immuno-inhibi-
tion on the ameliorative effect of PTH on
cartilage differentiation during acidosis. Con-
dyles were cultured for 3 days under control
(A ) or acidic conditions (B, C, D) in the pres-
ence (C, D), or absence (A, B) of 1010 mol/L
PTH and with (D) or without (C) anti-IGF-
I-R antibody (1/500 vol/vol). At the end of
the incubation period, cultures were routinely
fixed and processed for paraffin embedding.
Hybridization was performed under the con-
ditions described in the Methods section, in
the presence of 5 g/mL digoxygenin labeled
PGR (probe for the core protein of the carti-
lage proteoglycans). As shown, the recovery
effect of PTH on the expression of CSPG in
the acidic condyle (C) is blunted by immuno-
neutralization of IGF-IR (D).
and cartilage, thus having an autocrine-paracrine effect) The delay in chondrocyte maturation might allow cells
to add more cartilage, which can be subsequently miner-exert distinct effects on growth and differentiation of
the cartilage tissue in skeletal growth centers [34]. Both alized, thus serving as a scaffold for new bone. Along
these lines, overexpression of PTHrP inhibits the normalhormones bind to a unique G-protein coupled receptor
(type I PTH/PTHrP receptor) that is present on a variety transition to the hypertrophic zone resulting in various
skeletal dysplasias [24], whereas ablation of PTHrP orof cell types, including chondrocytes [13–15, 34]. Several
recent studies have demonstrated that PTH and PTHrP the PTH/PTHrP receptor results in a premature and
accelerated chondrocyte maturation [15, 23]. Our studydecrease terminal differentiation of chondrocytes [34].
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Fig. 12. Effects of acidosis and PTH on the levels of PKC: Western
analysis. Lysates derived from pools (10 to 15) of condyles cultured
under control and acidic conditions, with or without 1010 mol/L PTH,
were separated on SDS-PAGE, electroblotted onto nitrocellulose mem-
branes, and reacted with mouse anti PKC (cat. No SC 8393, Santa
Cruz Biotechnology) antibodies. Equal amounts of protein were loaded
onto each lane. The blot demonstrates a marked decrease in the levels
of PKC during acidotic conditions (compared to control). PTH up-
regulates PKC in both control and acidic conditions.Fig. 11. Effects of acidosis and PTH on the expression of IGF-I binding
protein 4 (IGFBP-4). Mandibular condyles were cultured for 3 days
under control (A, C) or acidic conditions (B, D), in the presence (C, D)
or absence (A, B) of 1010 mol/L PTH, and processed for paraffin
embedding as described in Methods section. Following peroxidase when using anti IGF-I-R antibody. IGF-I plays a crucialblocking and permeabilization, deparaffinized sections were reacted
role in preserving the integrity of endochondral bonewith 5 g/mL digoxygenin-labeled IGF-I binding protein-4 (IGFBP-4,
444 bp cloned in pBluescript SKamp). Hybridization conditions and formation, thereby promoting linear skeletal growth
detection of the hybrids were carried out as described in the Methods [10, 12]. This hormone is produced systemically by thesection. As shown, acidosis (B) increases the expression of IGFBP-4.
action of growth hormone (GH) but it is produced locallyThis increase is prevented by PTH (D vs. B).
also in various tissues including osteoblasts and cartilage
cells in skeletal growth centers [36]. We have recently
shown that CMA in vitro exerts deleterious effects on
demonstrates that the effect of PTH is not only exerted the function of the GH-IGF-I axis in skeletal growth
at the level of late stages of chondrocyte differentiation centers [9]. Thus, CMA brings about down-regulation
(that is, hypertrophic cell layer), but that these hormones of GH and IGF-I receptors and stimulates the produc-
(PTH/PTHrP) can influence and promote proliferation tion of IGF-I binding proteins (IGFBPs) 2 and 4, both
and differentiation of cartilage cells at the level of chon- of which antagonize the effects of IGF-I. The combined
droprogenitor and young chondrocytic cells, as well. effects of reduced IGF-I receptors and increased IGFBPs
These data are consistent with the finding by Suda et al by CMA lead to end organ resistance to the biological
showing that in the mandibular condyle, type I PTH/ effects of IGF-I on both proliferation and differentiation
PTHrP receptor resides in all cell layers of the condylar in skeletal growth centers [9]. This probably accounts
cartilage [35]. As such, PTH and PTHrP stimulate prolif- for the impaired endochondral bone formation and de-
eration of all cell layers of the condyle (thereby affecting fective linear growth in children suffering from chronic
mandibular length as shown in Fig. 3), delay the terminal acidotic states [2, 4]. With this background in mind, we
differentiation of hypertrophic cells, and promote differ- now demonstrate that PTH, by promoting the generation
entiation of younger chondrocytic cells (for example, of IGF-I under control and acidic conditions, is able to
expression CSPG, IGF-I, IGF-I-R and type II collagen). prevent the adverse effects of CMA on the integrity
Our study shows that the salutary effects of PTH/ of endochondral bone development. In addition to the
PTHrP on growth and phenotypic expression of the man- stimulatory effect of PTH on IGF-I production, PTH
dibular condyle overcome the adverse effects of CMA probably prevents the CMA-induced end organ resis-
on growth and differentiation of the condylar cartilage. tance to IGF-I. This ameliorative effect is achieved by
This effect is attributable, in part, to the stimulatory both increased expression and abundance of IGF-I re-
effect of PTH/PTHrP on IGF-I production since the ceptors and by the abrogation of increased IGFBP-4
induced by CMA.effect of PTH on cartilage differentiation was abrogated
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Fig. 13. Effects of phorbol 12-myristate 13-
acetate (PMA) on the expression of cartilage
proteoglycans under control and acidic condi-
tions. Mandibular condyles were cultured for
3 days under control (A, C) or acidic condi-
tions (B, D), in the presence (C, D) or absence
(A, B) of 108 mol/L PMA (cat. No p8139;
Sigma Chemical Co.), and processed for paraf-
fin embedding as described in Methods sec-
tion. Following peroxidase blocking and per-
meabilization, deparaffinized sections were
reacted with 5 g/mL digoxygenin labeled
PGR (922 bp probe for the core protein of
the cartilage proteoglycans). Hybridization
conditions and detection of the hybrids were
carried out as described in the Methods sec-
tion. As shown, the acidosis-induced decline
in the expression of proteoglycans (B) is com-
pletely prevented by PMA (D).
Our study also attempted to partially elucidate the mimics the effects of PTH during control and acidic
conditions, it is conceivable that PKC mediates, in part,signaling mechanisms that mediate the respective effects
of CMA and PTH on the chondrocyte phenotype in the salutary effects of PTH on chondrocyte differentia-
tion in growth centers. It is probable, however, that otherskeletal growth centers. Following binding to their com-
mon receptor (that is, type 1 receptor), PTH and PTHrP signaling pathways are operative as well. For example,
chondrocyte differentiation could be modulated by theactivate two major transduction pathways: (a) stimula-
tion of adenylyl cyclase to the cAMP dependent activa- cAMP/PKA pathway, which leads to phosphorylation of
cAMP response element binding protein (CREB) [37].tion of protein kinase A (PKA); and (b) phosphoinositol
breakdown by phospholipase C followed by the activa- The signals located downstream of PKC or cAMP in the
PTH signaling pathway need to be further elucidated.tion of protein kinase C (PKC) and an increase of intra-
cellular Ca2. PKC recently has been shown to exert The anabolic effects of PTH in skeletal growth centers,
as shown here, are a reflection of the pleiotropic effectsprofound and preliotropic effects on chondrocyte differ-
entiation. This signaling pathway also mediates the ef- of PTH on bone metabolism at different parts of the
skeleton. It is now clearly established that PTH exertsfects of various calciotropic hormones (such as PTH, 1,25
vitamin D3, and estrogens) on chondrocyte phenotypic either bone forming or bone resorbing activity depending
on the dosage and mode of administration of the hor-expression in growth centers [30, 31]. Based on these
lines of evidence, we explored the role of PKC in our mone (that is, continuous vs. intermittent mode). Whereas
continuous infusion of the hormone causes a loss of boneorgan culture system. We have shown that PKC- is
markedly down-regulated during acidic conditions. In through stimulation of resorption, intermittent low doses
lead to an increase of skeletal mass as a result of acceler-contrast, PTH augments PKC- abundance both during
control and acidic conditions. Furthermore, activation ated formation [38]. The anabolic effects of PTH are
exerted at different steps of bone formation (such as,of PKC by phorbol esters results in stimulation of chon-
drocyte differentiation as assessed by CSPG expression. stimulation of osteoblastic proliferation, increased min-
eral apposition and synthesis of type I collagen) [39].Activation of PKC also prevents the negative effects of
CMA on CSPG expression. Inasmuch as PKC activation These effects are mediated through the activation of
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mal stature with alkali therapy in infants and children with classicIGF-I expression in osteoblasts, which is induced by PTH
renal tubular acidosis. J Clin Invest 61:509–527, 1978
[26–28]. The search for an effective treatment of osteopo- 5. Bushinsky DA: The contribution of acidosis to renal osteodystro-
phy. Kidney Int 47:1816–1832, 1995rosis has drawn much attention to the bone forming
6. Sebastian A, Harris ST, Ottaway JH, et al: Improved mineralactivity of PTH. In fact, in both experimental animals
balance and skeletal metabolism in post-menopausal women
with different models of osteoporosis [16, 17], and in treated with potassium bicarbonate. N Engl J Med 330:1776–1781,
1994clinical osteoporosis in humans, (such as postmenopausal
7. Bushinsky DA: Net calcium efflux from live bone during chronicosteoporosis), PTH given intermittently has been shown
metabolic but not respiratory acidosis. Am J Physiol 256:F836–
to prevent and reverse bone loss and to decrease the F842, 1989
8. Bushinsky DA: Stimulated osteoclastic and suppressed osteoblas-risk of fractures [18–20]. Consistent with this informa-
tic activity in metabolic but not respiratory acidosis. Am J Physioltion, our study demonstrates that under certain condi-
268:C80–C88, 1995
tions, PTH can exert anabolic effects not only on bone 9. Green J, Maor G: Effect of metabolic acidosis on the growth
hormone/IGF-I endocrine axis in skeletal growth centers. Kidneycells, but also on the cartilaginous part of bone (that is,
Int 57:2258–2267, 2000growth centers).
10. Ohlsson C, Bengtsson BA, Isaksson OGP, et al: Growth hor-
The anabolic effects of IGF-I on the process of endo- mone and bone. Endocr Rev 19:55–79, 1998
11. Johansson AG, Lindh E, Ljunghall S: Insulin-like growth factorchondral bone formation contribute significantly to lin-
I stimulates bone turnover in osteoporosis. Lancet 339:1619–1622,ear skeletal growth [10, 12], whereas anabolic effects of
1992
the hormone in osteoblasts are responsible for a positive 12. Green H, Morikawa M, Nixon T: A dual effector theory of
growth-hormone action. Differentiation 29:195–198, 1985bone remodeling balance, namely increased bone forma-
13. Abou Samra AB, Juppner H, Freeman MW, et al: Expressiontion [10, 11]. Chronic metabolic acidosis (such as renal
cloning of a common receptor for parathyroid hormone and para-
tubular acidosis and uremic acidosis in chronic renal thyroid hormone-related peptide from rat osteoblast-like cells. A
single receptor stimulates intracellular accumulation of both cAMPfailure) exerts negative effects on the integrity of endo-
and inositol triphosphates and increases intracellular free calcium.chondral ossification in skeletal growth centers [9], thereby
Proc Natl Acad Sci USA 89:2732–2736, 1992
contributing to stunted growth in children suffering from 14. Juppner H, Samra AB, Freeman M, et al: A G protein-linked
receptor for parathyroid hormone and parathyroid hormone-relatedchronic acidosis. In addition, CMA also adversely affects
peptide. Science 254:1024–1026, 1991bone cell function, which in turn contributes to the patho- 15. Karaplis AC, Luz A, Glowacki J, et al: Lethal skeletal dysplasia
genesis of osteoporosis and azotemic osteodystrophy [5]. from targeted disruption of the parathyroid hormone-related pep-
tide gene. Genes Dev 8:277–289, 1994Given the suppressive effects of CMA on the GH/IGF-I
16. Hefti E, Trechsel U, Bonjour JP, et al: Increase of whole bodyendocrine axis in skeletal growth centers, shown here calcium and skeletal mass in normal and osteoporotic adult rats
and in our previous study [9], and assuming that a similar treated with parathyroid hormone. Clin Sci 62:389–396, 1982
17. Gunness-Hey M, Hock JM: Increased tubular bone mass in ratsphenomenon takes place in adult bone as well, it is con-
treated with human synthetic parathyroid hormone. Metab Boneceivable that the deleterious effects of CMA on skeletal Dis. 5:177–181, 1984
metabolism are mediated in part through the suppression 18. Reeve J, Williams D, Hesp R, et al: Anabolic effects of low doses
of a fragment of human parathyroid hormone on the skeleton inof the GH/IGF-I axis. The present study suggests that
postmenopausal osteoporosis. Lancet 1:1035–1038, 1976PTH at a low concentration exerts anabolic effects in the 19. Reeve J, Meunier PJ, Parsons JA, et al: Anabolic effect of human
cartilage tissue of growth centers (similar to its salutary PTH on trabecular bone in involutional osteoporosis: a multicenter
trial. BMJ 280:1340–1344, 1980effects on osteoblast function and bone formation). Fur-
20. Neer RM, Arnaud CD, Zanchetta JR, et al: Effect of parathyroidthermore, these anabolic effects of PTH in cartilaginous hormone (1–34) on fractures and bone mineral density in post-
bone tissue can be utilized to reverse the adverse effects menopausal women with osteoporosis. N Engl J Med. 344:1434–
1441, 2001of acidosis in growth centers.
21. Lanske B, Karaplis AC, Lee K, et al: PTH/PTHrP receptor in
early development and Indian–Hedgehog-regulated bone growth.
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